The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas
Despite being in the same pathway, mutations of KRAS and BRAF in colorectal carcinomas (CRCs) determine distinct progression courses. ZEB1 induces an epithelial-to-mesenchymal transition (EMT) and is associated with worse progression in most carcinomas. Using samples from patients with CRC, mouse mo...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical investigation
2023-10-01
|
| Серии: | JCI Insight |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1172/jci.insight.164629 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|